loading

Black Diamond Therapeutics Inc Azioni (BDTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- 70.00 - -
Operating Expenses
18.20%
10.98
13.42 15.47 18.27 18.13
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
18.20%
10.98
13.42 15.47 - -
Operating Income/Loss
18.20%
-10.98
-13.42 54.53 -18.27 -18.13
Nonoperating Income/Loss
13.26%
2.48
2.859 2.012 2.29 2.573
Income/Loss From Continuing Operations Before Tax
19.53%
-8.498
-10.56 56.54 -15.98 -15.56
Income/Loss From Continuing Operations After Tax
19.53%
-8.498
-10.56 56.54 -15.98 -15.56
Net Income/Loss
19.53%
-8.498
-10.56 56.54 -15.98 -15.56
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.22%
56.93
56.80 56.66 0.5303 56.51
Diluted Average Shares
0.22%
56.93
56.80 57.67 0.5303 56.51
Basic Earnings Per Share
21.05%
-0.15
-0.19 1.00 -0.28 -0.28
Diluted Earnings Per Share
21.05%
-0.15
-0.19 0.98 -0.28 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):